Dabigatran experience in primary and secondary prevention of cardioembolic stroke

por Maksim Alekseyevich Domashenko, M Yu Maksimova, D Z Korobkova, M E Gafarova
Publicado em 2013-11-01

Efficacy and safety of anti-CGRP(r) monoclonal antibodies in real clinical practice: preliminary analysis after three months of therapy

por N. V. Vashchenko, D. Z. Korobkova, K. V. Skorobogatykh, Yu. E. Azimova
Publicado em 2021-12-01

Six-month therapy of CGRP monoclonal antibodies in real-world clinical practice: an interim analysis of efficacy and safety data

por N. V. Vashchenko, A. M. Uzhakhov, M. V. Bogorodskaya, D. Z. Korobkova, Ju. E. Azimova, K. V. Skorobogatykh
Publicado em 2022-01-01